Company Filing History:
Years Active: 1989-2003
Title: Innovations by Takeshi Fujiyasu
Introduction
Takeshi Fujiyasu is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of veterinary medicine, particularly in the development of novel cytokine proteins for feline health. With a total of 4 patents, his work focuses on enhancing the immune response in cats against infectious diseases.
Latest Patents
Fujiyasu's latest patents include a groundbreaking feline cytokine protein that enhances the cytotoxic activity of feline cytotoxic T lymphocytes. This invention encompasses a DNA sequence coding for the protein, a recombinant DNA for its expression, and an expression vector that includes this recombinant DNA. Additionally, he has developed a transformant that is transformed with the expression vector, a process for preparing the protein by culturing the transformant, and an antibody against the protein. The novel cytokine protein is a heterologous dimer comprising FLAF p35 and FLAF p40, which can be utilized for treating feline infectious diseases such as feline herpes virus type 1 (FHV-1) and feline calicivirus (FCV).
Career Highlights
Fujiyasu is affiliated with the Juridical Foundation the Chemo-sero-therapeutic Research Institute, where he conducts his research and development activities. His innovative work has positioned him as a key figure in the advancement of treatments for feline diseases.
Collaborations
Some of his notable coworkers include Takayuki Imamura and Hiroaki Maeda, who contribute to the collaborative efforts in research and development within the institute.
Conclusion
Takeshi Fujiyasu's contributions to veterinary medicine through his innovative cytokine protein patents highlight his commitment to improving feline health. His work continues to pave the way for advancements in the treatment of infectious diseases in cats.